04/28/2026
In the news: Dr. Tangir on GLP-1 medications 📰
GLP-1 medications like Ozempic and Wegovy are making headlines for their impact on weight loss and overall health. As research continues to evolve, there is growing interest in how these medications may influence cancer risk.
Our own Dr. Jacob Tangir shared insight on what we know so far when it comes to gynecologic health:
By helping reduce obesity, a known risk factor, these medications may play a role in lowering the risk of endometrial cancer. Emerging data also suggests they may help improve certain precancerous conditions of the uterine lining when used alongside appropriate treatment.
While research is still ongoing, this highlights an important point. Managing overall health, including weight, can have a meaningful impact on gynecologic cancer risk. 💙
If you have questions about your risk factors or your gynecologic health, we are here to help guide you.
You can read the full article here:
https://www.orlandosentinel.com/2026/04/25/i-intend-to-stay-on-it-forever-along-with-rapid-weight-loss-patients-see-other-benefits-and-risks-of-glp-1-drugs/
📞 Call (954) 602-9723 to schedule an appointment
🌐 Visit www.toplinemd.com/gynecologic-oncology-center/